|
nasdaq:rxdx
|
www.ignyta.com
|
www.ignyta.com
|
Apr 27th, 2017 12:00AM
|
Intern - Accounting
|
Open
|
|
Accounting
|
|
San Diego
|
CA
|
USA
|
Apr 26th, 2017 12:00AM
|
|
|
|
|
|
|
Apr 27th, 2017 05:41AM
|
Apr 27th, 2017 05:41AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.ignyta.com
|
www.ignyta.com
|
Apr 28th, 2017 12:00AM
|
Intern - Accounting
|
Open
|
|
Accounting
|
|
San Diego
|
CA
|
USA
|
Apr 26th, 2017 12:00AM
|
|
|
|
|
|
|
Apr 28th, 2017 03:23AM
|
Apr 28th, 2017 03:23AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.ignyta.com
|
www.ignyta.com
|
Apr 29th, 2017 12:00AM
|
Intern - Accounting
|
Open
|
|
Accounting
|
|
San Diego
|
CA
|
USA
|
Apr 26th, 2017 12:00AM
|
|
|
|
|
|
|
Apr 29th, 2017 04:27AM
|
Apr 29th, 2017 04:27AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.ignyta.com
|
www.ignyta.com
|
Apr 30th, 2017 12:00AM
|
Intern - Accounting
|
Open
|
|
Accounting
|
|
San Diego
|
CA
|
USA
|
Apr 26th, 2017 12:00AM
|
|
|
|
|
|
|
Apr 30th, 2017 03:08AM
|
Apr 30th, 2017 03:08AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.ignyta.com
|
www.ignyta.com
|
May 1st, 2017 12:00AM
|
Intern - Accounting
|
Open
|
|
Accounting
|
|
San Diego
|
CA
|
USA
|
Apr 26th, 2017 12:00AM
|
|
|
|
|
|
|
May 1st, 2017 02:20AM
|
May 1st, 2017 02:20AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.ignyta.com
|
www.ignyta.com
|
May 2nd, 2017 12:00AM
|
Intern - Accounting
|
Open
|
|
Accounting
|
|
San Diego
|
CA
|
USA
|
Apr 26th, 2017 12:00AM
|
|
|
|
|
|
|
May 2nd, 2017 03:38AM
|
May 2nd, 2017 03:38AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.ignyta.com
|
www.ignyta.com
|
May 3rd, 2017 12:00AM
|
Intern - Accounting
|
Open
|
|
Accounting
|
|
San Diego
|
CA
|
USA
|
Apr 26th, 2017 12:00AM
|
|
|
|
|
|
|
May 3rd, 2017 03:17AM
|
May 3rd, 2017 03:17AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.ignyta.com
|
www.ignyta.com
|
May 4th, 2017 12:00AM
|
Intern - Accounting
|
Open
|
|
Accounting
|
|
San Diego
|
CA
|
USA
|
Apr 26th, 2017 12:00AM
|
|
|
|
|
|
|
May 4th, 2017 05:17AM
|
May 4th, 2017 05:17AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.prometheusbiosciences.com
|
www.prometheusbiosciences.com
|
Nov 23rd, 2022 12:00AM
|
Vice President, Clinical Development
|
Open
|
|
Clinical Development
|
San Diego, California, United States
|
San Diego
|
California
|
USA
|
Nov 9th, 2022 12:00AM
|
|
{
"@context": "http://schema.org",
"@type": "JobPosting",
"datePosted": "2022-11-09",
"description": "<div><div><div><p style=\"font-size: 10.0pt;line-height: 6.0%;margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 10.0pt;\">\u00A0</span></p></div><p style=\"margin: 0.0pt;\"><img src=\"data:image/png;base64,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\" width=\"204\" height=\"45\" alt=\"\" /></p><p style=\"background-color: rgb(255,255,255);line-height: 15.0pt;margin: 0.0pt;\"><span style=\"color: rgb(38,50,56);font-family: Calibri;font-size: 12.0pt;font-weight: bold;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Vice President, Clinical Development</span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">- </span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">San Diego</span></p><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">We\u2019re a different kind of biotech company.</span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">And we\u2019re here to make a difference.</span></p><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Prometheus Biosciences, Inc. (Nasdaq: RXDX), is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">development,</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">The Company\u2019s precision medicine platform, Prometheus360\u2122, combines proprietary machine learning-based analytical approaches with one of the world\u2019s largest gastrointestinal bioinformatics databases to identify novel therapeutic targets and develop therapeutic candidates to engage those targets.</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\"> Headquartered in San Diego, Prometheus Biosciences, Inc. was named Best Places to Work by</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">Biospace, San Diego Business Journal and is a Great Place to Work-Certified\u2122 Company.</span></p><p style=\"background-color: rgb(255,255,255);margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);line-height: 11.0pt;margin: 0.0pt;text-align: justify;\"><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Summary</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><br /><span style=\"font-family: Calibri;font-size: 11.0pt;\">Prometheus Biosciences is seeking a highly motivated hands-on physician leader to serve as Vice President, Clinical Development who</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0will lead a portfolio of the company\u2019s clinical studies to include the company\u2019s Phase II SSC-ILD program, PRA052 currently in Phase I for Ulcerative Colitis, as well as future indications that are to be selected</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">.\u00A0<br /><br /> </span></p><p style=\"font-size: 11.0pt;line-height: 110.0%;margin: 0.0pt;text-align: justify;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">This position will play a key role in driving the execution of studies from indication selection, protocol concept, </span><span style=\"font-family: Calibri;font-size: 11.0pt;\">design,</span><span style=\"font-family: Calibri;font-size: 11.0pt;\"> and conduct, to final report including interpretation of clinical data, and preparation of documents for filing with regulatory agencies.<br /><br /> </span></p><p style=\"font-size: 11.0pt;line-height: 110.0%;margin: 0.0pt;text-align: justify;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">As a subject matter expert, the incumbent will work with key stakeholders on the development of clinical protocols to support the company\u2019s product strategy, data collection and management, and final reports development in compliance with appropriate standard operating procedures, and regulatory and medical standards. This position interacts with various groups within the company and externally to the business to ensure alignment and oversee clinical research activities.</span></p><p style=\"font-size: 11.0pt;line-height: 110.0%;margin: 0.0pt;text-align: justify;\"><a></a><span style=\"font-family: Calibri;font-size: 11.0pt;\">There is an opportunity for the position to be developed to lead global product development based on a candidate\u2019s experience and interests.</span></p><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\"><br />Key Duties and</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Responsibilities</span></p><ul style=\"margin: 0.0pt;padding-left: 0.0pt;\"><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Provide clinical leadership of trial execution from first-in-human through registrational studies.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Provide clinical leadership in the conduct of clinical activities including recruitment, data review, analysis, and reporting that conforms to the highest ethical, safety and quality standards and in compliance with GCP and regulatory standards.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Attend and present at investigator meetings and site initiation visits as applicable.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Provide clinical leadership in the preparation of Clinical Study Reports, Annual Reports and other safety reports, Health Authority pre-meeting packages, Investigator Brochures and other periodic clinical reports.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Collaborating with cross-functional groups to provide input in publication strategy including active participation in authoring, preparation, and review of manuscripts, conference abstracts and presentations, and other external presentations of clinical data.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Partner with R&D to provide clinical perspective to target selection and development strategy. Offer clinical input/direction on early-stage, pre-clinical projects.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Remain current on the therapeutic landscape in the relevant therapeutic areas through review of the scientific literature, interactions with key opinion leaders and other external experts, and attendance at relevant scientific meetings, in order to provide input and guidance for the strategic </span><span style=\"font-family: Calibri;font-size: 11.0pt;\">direction of Prometheus Biosciences\u2019 programs.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Partner with Medical Affairs on the overall strategy for Target Product Profiles, clinical trial design, and ensuring dissemination of medically accurate information related to Prometheus\u2019 product candidates. </span></li></ul><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\"><br />Education</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">and</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Experience</span></p><ul style=\"margin: 0.0pt;padding-left: 0.0pt;\"><li style=\"background-color: rgb(255,255,255);font-family: serif;font-size: 11.0pt;line-height: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">MD degree or equivalent is required. Board Certification or Board Eligibility in internal medicine, subspecialty training or experience in drug development in gastroenterology, rheumatology, immunology, or pulmonary medicine is highly desirable.</span></li></ul><ul style=\"margin: 0.0pt;padding-left: 0.0pt;\"><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">A minimum of 10+ years of experience in pharmaceutical clinical drug development in industry including protocol development; study initiation and follow-up; IRB/EC submissions and interactions; review of clinical study data listings; review and/or preparation of clinical study reports. </span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">The candidate should have experience with U.S. and European Health Authority interactions and have experience with submissions of clinical regulatory documents.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">A clinical background that includes experience in inflammatory or immune-mediated diseases a plus (rheumatology</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">, dermatology, pulmonology, etc). However, experience working across broad disease areas with an aptitude for learning equally desired. </span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Exceptional execution, and implementation of practices and initiatives to ensure timelines and budgets are met.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">The ability to build and maintain excellent interpersonal relationships, both within and outside the company, at all levels.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">A hands-on, entrepreneurial style with a sense of urgency, a bias toward action, comfort with calculated risk, and the ability to analyze situations rapidly and make prudent decisions.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 12.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Engaged, hands-on, </span><span style=\"font-family: Calibri;font-size: 11.0pt;\">independent,</span><span style=\"font-family: Calibri;font-size: 11.0pt;\"> and goal-oriented mentality; willingness to work in</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0a\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">highly dynamic work environment and embrace uncertainty.</span></li></ul><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Skills and Abilities</span></p><ul style=\"margin: 0.0pt;padding-left: 0.0pt;\"><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">H</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">ighly dynamic work environment and embrace uncertainty.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Ability to multi-task and willingness to flexibly contribute simultaneously in multiple facets of drug development; willingness to learn new therapeutic areas.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Self-motivated; strong commitment to follow up on tasks and action items; organizational, analytical, and problem-solving skills; risk identification and management; creative and innovative thinking all highly desirable.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Strong ability to work within and lead and motivate a cross-functional matrixed team.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">The requisite scientific acumen and communication skills to influence and collaborate with key scientific, regulatory, and business leaders.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Sound strategic, clinical, technical, operational, and ethical judgment with uncompromising integrity.</span><span style=\"color: rgb(38,50,56);font-family: Calibri;font-size: 12.0pt;font-weight: bold;\"> </span></li></ul><p style=\"margin: 0.0pt 0.0pt 0.0pt 36.0pt;text-align: justify;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"margin: 0.0pt 0.0pt 12.0pt 36.0pt;text-align: justify;\"><img src=\"data:image/png;base64,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
|
|
|
|
|
Nov 23rd, 2022 11:39AM
|
Nov 23rd, 2022 11:39AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:rxdx
|
www.prometheusbiosciences.com
|
www.prometheusbiosciences.com
|
Nov 24th, 2022 12:00AM
|
Vice President, Clinical Development
|
Open
|
|
Clinical Development
|
San Diego, California, United States
|
San Diego
|
California
|
USA
|
Nov 9th, 2022 12:00AM
|
|
{
"@context": "http://schema.org",
"@type": "JobPosting",
"datePosted": "2022-11-09",
"description": "<div><div><div><p style=\"font-size: 10.0pt;line-height: 6.0%;margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 10.0pt;\">\u00A0</span></p></div><p style=\"margin: 0.0pt;\"><img src=\"data:image/png;base64,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\" width=\"204\" height=\"45\" alt=\"\" /></p><p style=\"background-color: rgb(255,255,255);line-height: 15.0pt;margin: 0.0pt;\"><span style=\"color: rgb(38,50,56);font-family: Calibri;font-size: 12.0pt;font-weight: bold;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Vice President, Clinical Development</span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">- </span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">San Diego</span></p><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">We\u2019re a different kind of biotech company.</span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">And we\u2019re here to make a difference.</span></p><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Prometheus Biosciences, Inc. (Nasdaq: RXDX), is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">development,</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">The Company\u2019s precision medicine platform, Prometheus360\u2122, combines proprietary machine learning-based analytical approaches with one of the world\u2019s largest gastrointestinal bioinformatics databases to identify novel therapeutic targets and develop therapeutic candidates to engage those targets.</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\"> Headquartered in San Diego, Prometheus Biosciences, Inc. was named Best Places to Work by</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">Biospace, San Diego Business Journal and is a Great Place to Work-Certified\u2122 Company.</span></p><p style=\"background-color: rgb(255,255,255);margin: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"background-color: rgb(255,255,255);line-height: 11.0pt;margin: 0.0pt;text-align: justify;\"><span style=\"font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Summary</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span><br /><span style=\"font-family: Calibri;font-size: 11.0pt;\">Prometheus Biosciences is seeking a highly motivated hands-on physician leader to serve as Vice President, Clinical Development who</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0will lead a portfolio of the company\u2019s clinical studies to include the company\u2019s Phase II SSC-ILD program, PRA052 currently in Phase I for Ulcerative Colitis, as well as future indications that are to be selected</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">.\u00A0<br /><br /> </span></p><p style=\"font-size: 11.0pt;line-height: 110.0%;margin: 0.0pt;text-align: justify;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">This position will play a key role in driving the execution of studies from indication selection, protocol concept, </span><span style=\"font-family: Calibri;font-size: 11.0pt;\">design,</span><span style=\"font-family: Calibri;font-size: 11.0pt;\"> and conduct, to final report including interpretation of clinical data, and preparation of documents for filing with regulatory agencies.<br /><br /> </span></p><p style=\"font-size: 11.0pt;line-height: 110.0%;margin: 0.0pt;text-align: justify;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">As a subject matter expert, the incumbent will work with key stakeholders on the development of clinical protocols to support the company\u2019s product strategy, data collection and management, and final reports development in compliance with appropriate standard operating procedures, and regulatory and medical standards. This position interacts with various groups within the company and externally to the business to ensure alignment and oversee clinical research activities.</span></p><p style=\"font-size: 11.0pt;line-height: 110.0%;margin: 0.0pt;text-align: justify;\"><a></a><span style=\"font-family: Calibri;font-size: 11.0pt;\">There is an opportunity for the position to be developed to lead global product development based on a candidate\u2019s experience and interests.</span></p><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\"><br />Key Duties and</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Responsibilities</span></p><ul style=\"margin: 0.0pt;padding-left: 0.0pt;\"><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Provide clinical leadership of trial execution from first-in-human through registrational studies.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Provide clinical leadership in the conduct of clinical activities including recruitment, data review, analysis, and reporting that conforms to the highest ethical, safety and quality standards and in compliance with GCP and regulatory standards.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Attend and present at investigator meetings and site initiation visits as applicable.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Provide clinical leadership in the preparation of Clinical Study Reports, Annual Reports and other safety reports, Health Authority pre-meeting packages, Investigator Brochures and other periodic clinical reports.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Collaborating with cross-functional groups to provide input in publication strategy including active participation in authoring, preparation, and review of manuscripts, conference abstracts and presentations, and other external presentations of clinical data.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Partner with R&D to provide clinical perspective to target selection and development strategy. Offer clinical input/direction on early-stage, pre-clinical projects.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Remain current on the therapeutic landscape in the relevant therapeutic areas through review of the scientific literature, interactions with key opinion leaders and other external experts, and attendance at relevant scientific meetings, in order to provide input and guidance for the strategic </span><span style=\"font-family: Calibri;font-size: 11.0pt;\">direction of Prometheus Biosciences\u2019 programs.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 8.85pt;padding-left: 27.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Partner with Medical Affairs on the overall strategy for Target Product Profiles, clinical trial design, and ensuring dissemination of medically accurate information related to Prometheus\u2019 product candidates. </span></li></ul><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\"><br />Education</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">and</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">\u00A0</span><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Experience</span></p><ul style=\"margin: 0.0pt;padding-left: 0.0pt;\"><li style=\"background-color: rgb(255,255,255);font-family: serif;font-size: 11.0pt;line-height: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">MD degree or equivalent is required. Board Certification or Board Eligibility in internal medicine, subspecialty training or experience in drug development in gastroenterology, rheumatology, immunology, or pulmonary medicine is highly desirable.</span></li></ul><ul style=\"margin: 0.0pt;padding-left: 0.0pt;\"><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">A minimum of 10+ years of experience in pharmaceutical clinical drug development in industry including protocol development; study initiation and follow-up; IRB/EC submissions and interactions; review of clinical study data listings; review and/or preparation of clinical study reports. </span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">The candidate should have experience with U.S. and European Health Authority interactions and have experience with submissions of clinical regulatory documents.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">A clinical background that includes experience in inflammatory or immune-mediated diseases a plus (rheumatology</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">, dermatology, pulmonology, etc). However, experience working across broad disease areas with an aptitude for learning equally desired. </span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Exceptional execution, and implementation of practices and initiatives to ensure timelines and budgets are met.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">The ability to build and maintain excellent interpersonal relationships, both within and outside the company, at all levels.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">A hands-on, entrepreneurial style with a sense of urgency, a bias toward action, comfort with calculated risk, and the ability to analyze situations rapidly and make prudent decisions.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 12.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Engaged, hands-on, </span><span style=\"font-family: Calibri;font-size: 11.0pt;\">independent,</span><span style=\"font-family: Calibri;font-size: 11.0pt;\"> and goal-oriented mentality; willingness to work in</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0a\u00A0</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">highly dynamic work environment and embrace uncertainty.</span></li></ul><p style=\"background-color: rgb(255,255,255);line-height: 18.0pt;margin: 0.0pt;\"><span style=\"background-color: rgb(255,255,255);font-family: Calibri;font-size: 11.0pt;font-weight: bold;\">Skills and Abilities</span></p><ul style=\"margin: 0.0pt;padding-left: 0.0pt;\"><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">H</span><span style=\"font-family: Calibri;font-size: 11.0pt;\">ighly dynamic work environment and embrace uncertainty.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Ability to multi-task and willingness to flexibly contribute simultaneously in multiple facets of drug development; willingness to learn new therapeutic areas.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Self-motivated; strong commitment to follow up on tasks and action items; organizational, analytical, and problem-solving skills; risk identification and management; creative and innovative thinking all highly desirable.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Strong ability to work within and lead and motivate a cross-functional matrixed team.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">The requisite scientific acumen and communication skills to influence and collaborate with key scientific, regulatory, and business leaders.</span></li><li style=\"font-family: serif;font-size: 11.0pt;margin: 0.0pt 0.0pt 0.0pt 26.85pt;padding-left: 9.15pt;text-align: justify;text-indent: 0.0pt;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">Sound strategic, clinical, technical, operational, and ethical judgment with uncompromising integrity.</span><span style=\"color: rgb(38,50,56);font-family: Calibri;font-size: 12.0pt;font-weight: bold;\"> </span></li></ul><p style=\"margin: 0.0pt 0.0pt 0.0pt 36.0pt;text-align: justify;\"><span style=\"font-family: Calibri;font-size: 11.0pt;\">\u00A0</span></p><p style=\"margin: 0.0pt 0.0pt 12.0pt 36.0pt;text-align: justify;\"><img src=\"data:image/png;base64,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
|
|
|
|
|
Nov 24th, 2022 11:22AM
|
Nov 24th, 2022 11:22AM
|
Prometheus Biosciences
|
Health Care
|
Health Care Equipment & Services
|